Fractyl Labs
IPO
Transformative Metabolic Therapies
- Headquarters
- Boston, Massachusetts
- Employees
- 51–200
- Founded
- 2011
- Business Model
- B2B
- Website
- fractyl.com
- Total Funding
- $339.0M
- Last Round
- $60.0M Venture RoundSep 2025
About
Fractyl Health (formerly Fractyl Labs) is a clinical-stage metabolic therapeutics company developing breakthrough therapies targeting root causes of obesity and type 2 diabetes. Its lead platform, Revita, is an outpatient endoscopic procedure designed to resurface the duodenal lining. The company also develops Rejuva, a gene therapy platform targeting pancreatic islet cells for long-term metabolic disease remission.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account